▲ Peaking
Business
Biogen defends anti-tau drug after stock slides on Alzheimer’s readout
1sources
1articles
0velocity
+0%since first seen
just nowfirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (1)
- Biogen defends anti-tau drug after stock slides on Alzheimer’s readout Fierce Biotech · 18h ago
Related trends
▲ Peaking
Business
DeepSeek reportedly in talks to raise $1.5B, then IPO
DeepSeek initiates plans for a $1.5 billion capital raise and a prospective public listing as revenue figures show significant growth.
▲ Peaking
Business
Treasury yields rise as investors await latest producer price inflation data
Treasury yields are climbing as market participants position themselves ahead of upcoming producer price inflation data.
▲ Peaking
Business
US consumer inflation moderates; upside risks remain amid renewed Middle East conflict
▲ Peaking
Business
American AI is expensive. Some startups are turning to cheap Chinese models
▲ Peaking
Business
PayPal Shares Surge Premarket on Reports of $53 Billion Takeover Offer
▲ Peaking
Business
Morgan Stanley is set to report second-quarter earnings
Morgan Stanley reports a surge in second-quarter financial performance driven by increased activity in trading and corporate dealmaking.